Utah Medical Products Inc (UTMD): Ernst G Hoyer , director of Utah Medical Products Inc sold 63 shares on Sep 8, 2016. The Insider selling transaction was reported by the company on Sep 12, 2016 to the Securities and Exchange Commission. The shares were sold at $63.81 per share for a total value of $4,019.72 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on Sep 8, 2016, Ernst G Hoyer (director) sold 1,249 shares at $63.98 per share price.On Sep 8, 2016, Kevin L Cornwell (Chairman, CEO, Secretary) sold 408 shares at $64.06 per share price.Also, On Jun 1, 2016, Paul O Richins (VP, Treasurer, Asst Secretary) sold 396 shares at $64.50 per share price.
Utah Medical Products: On Monday, Sep 12, 2016 heightened volatility was witnessed in Utah Medical Products which led to swings in the share price. The shares opened for trading at $63.58 and hit $63.79 on the upside , eventually ending the session at $63.79, with a gain of 0.85% or 0.54 points. The heightened volatility saw the trading volume jump to 1,908 shares. The 52-week high of the share price is $68.9 and the company has a market cap of $240 M . The 52-week low of the share price is at $50.4.
On Aug 2, 2016, Utah Medical Products announced a cash dividend of $0.2600. The company’s management has announced Sep 14, 2016 as the ex-dividend date and fixed the record date on Sep 16, 2016. The payable date has been fixed on Oct 4, 2016.
Utah Medical Products Inc. (UTMD) is engaged in the business of producing medical devices. UTMD markets a range of medical devices used in critical care areas: neonatal intensive care unit (NICU) labor and delivery (L&D) department and women’s health center in hospitals as well as products sold to outpatient clinics and physician’s offices. Its products include INTRAN INTRAN PLUS TENDER TOUCH AROM-COT CORDGUARD Bari-Belts Bari-Bands BT-Cath DISPOSA-HOOD DELTRAN PLUS UMBILI-CATH NUTRI-CATH and NUTRI-LOK among others. UTMD’s product and process development projects are in the areas of augmentation and internal manufacturing of Femcare devices; specialized procedures for the assessment and treatment of cervical/uterine disease and product and process development for original equipment manufacturers (OEMs). Its products are sold to clinical end user facilities through specialty distributors national hospital distribution companies and other medical device manufacturers.